The lawsuit alleges that Insulet Corporation misled shareholders by failing to disclose critical defects in its manufacturing controls and procedures. According to the complaint, these internal failures created a heightened risk that products would violate safety regulations or cause potential injury. When these details eventually reached the market, investors claim to have suffered significant financial losses.
Those interested in serving as lead plaintiff must file a motion with the court no later than August 31, 2026. While the Rosen Law Firm is actively recruiting participants, investors retain the right to select their own counsel or remain absent class members. No class has been certified yet, meaning investors are not represented by any firm until they formally retain one. Participation in any future settlement does not strictly require serving as a lead plaintiff.





Comments (0)
No comments yet. Be the first!